Wearable Sensors and Video-Based Testing to Track Arm Function After Treatment for Neurogenic Thoracic Outlet Syndrome
Remote Assessment and Digital Biomarker-Based Testing for Neurogenic Thoracic Outlet Syndrome: Longitudinal Follow-up After Physical Therapy or Surgery (Study 2)
The goal of this study is to learn whether wearable motion sensors and video-based movement analysis can track changes in arm function over time in adults with neurogenic thoracic outlet syndrome (NTOS) who are receiving standard treatment (physical therapy or surgery).
NTOS happens when nerves between the neck and shoulder are squeezed, causing pain, numbness, weakness, and trouble using the arm. There is currently no objective test to measure how severe NTOS is or how well treatment is working.
The main questions this study aims to answer are:
- Can digital measurements of arm movement, collected with wearable sensors and with standard webcam video, detect changes in arm function after NTOS treatment?
- Are these digital measurements more sensitive to change than standard questionnaires?
- Do video-based measurements agree with sensor-based measurements?
- Can measurements taken before treatment help predict who will improve with physical therapy?
This study does not assign or change treatment. Physical therapy or surgery is chosen by each participant's doctors as part of usual care.
Participants will:
- Complete 5 study visits over about 12 months: before treatment and 1 and 2 months after treatment (in clinic), and 6 and 12 months after treatment (remote telemedicine visits)
- At each visit, perform a short arm movement task (the "Press Test," a 20-second hand-over-head exercise) while wearing motion sensors and/or being recorded on video
- Complete questionnaires about arm function, pain, mood, and overall health
研究概览
详细说明
Neurogenic thoracic outlet syndrome (NTOS) is a disorder of dynamic compression of the brachial plexus between the first rib and the scalene muscles. Diagnosis currently relies on subjective clinical assessment, and there are no objective measures to monitor response to treatment. This study evaluates a remote patient monitoring platform that extracts digital biomarkers of upper extremity motor function from the Press Test, a 20-second repetitive hand-over-head task designed to provoke NTOS symptoms.
This is a single-site, prospective longitudinal study at the UCLA Thoracic Outlet Syndrome Center. Adults with a treating-physician diagnosis of NTOS who are proceeding with standard-of-care treatment (physical therapy and/or surgery) are followed for 12 months. Treatment selection is made by the treating clinicians and is not assigned by the study. Approximately 50 participants undergoing physical therapy and 50 undergoing surgery will be enrolled.
At each of five time points (baseline 0-1 month before treatment; 1, 2, 6, and 12 months after treatment), participants perform the Press Test while digital biomarkers are captured with wearable inertial sensors and with AI-based analysis of standard webcam video. The baseline, 1-month, and 2-month assessments are performed in person; the 6- and 12-month assessments are performed remotely via secure telehealth, with sensors provided in clinic or mailed to the participant with written instructions and staff support. Patient-reported outcomes (DASH, VAS pain, Zung Self-Rating Depression Scale, and PROMIS Global Health) are collected at each time point. Feasibility and acceptability of remote assessment are evaluated through visit completion rates, time burden, technical issues, and a technology acceptance questionnaire.
Analyses will use linear and generalized linear mixed models to assess change over time, intraclass correlation coefficients and Bland-Altman analyses to compare sensor- and video-derived measures, and exploratory models to identify baseline predictors of response to physical therapy.
This study is funded by the National Institutes of Health (R01HD121303).
研究类型
注册 (估计的)
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Adults aged 18 to 60 years with a treating-physician diagnosis of neurogenic thoracic outlet syndrome who are evaluated at the UCLA Thoracic Outlet Syndrome Center and are proceeding with standard-of-care physical therapy or surgery.
描述
Inclusion Criteria:
- Men or women aged 18 to 60 years
- Treating-physician diagnosis of neurogenic thoracic outlet syndrome (NTOS)
- Plan for standard-of-care treatment (physical therapy and/or surgery) at UCLA
- Right-handed, left-handed, or ambidextrous
- Able to provide informed consent and complete study activities
Exclusion Criteria:
- Bilateral NTOS
- Previous surgery for NTOS at any time, or NTOS-directed physical therapy within the past 2 months
- Venous thoracic outlet syndrome
- Arterial thoracic outlet syndrome
- NTOS together with another condition affecting the upper extremity
- Cognitive impairment
- Acute or chronic conditions unrelated to NTOS that may affect upper extremity function (e.g., stroke, Parkinson's disease, arthritis, cancer)
- History of drug or alcohol abuse within the past 6 months
- Inability to participate in follow-up assessments (e.g., plans to move out of state within 12 months, or inability to complete remote follow-up visits)
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
|---|
|
Physical Therapy
Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care physical therapy. Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study. |
|
Surgery
Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care surgical decompression (e.g., first rib resection, scalenectomy, and brachial plexus neurolysis). Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Press Test Digital Biomarkers of Upper Extremity Function
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Digital biomarkers of upper extremity motor function (representing slowness, weakness, rigidity, exhaustion, and unsteadiness, e.g., speed, power, rise time, and range of motion) extracted from a 20-second repetitive hand-over-head Press Test using wearable inertial sensors and AI-based webcam video analysis. Change from baseline will be assessed at each follow-up time point. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
The DASH is a 30-item self-reported questionnaire of upper extremity disability and symptoms. Scores range from 0 to 100; higher scores indicate greater disability. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Pain Intensity (Visual Analog Scale)
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Self-reported pain intensity on a 0 to 10 visual analog scale; higher scores indicate worse pain. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Change in Zung Self-Rating Depression Scale (SDS) Score
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
20-item self-reported depression scale. Raw scores range from 20 to 80; higher scores indicate more severe depressive symptoms. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Change in PROMIS Global Health Physical and Mental Health T-Scores
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
PROMIS Global Health v1.2 (10 items) yields Global Physical Health and Global Mental Health T-scores (population mean 50, SD 10); higher scores indicate better health. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Agreement Between Sensor-Based and Video-Based Digital Biomarkers
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Agreement between digital biomarkers derived from wearable sensors and from AI-based webcam video analysis during the Press Test, assessed by intraclass correlation coefficient (ICC) at each time point. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Baseline Digital Biomarkers as Predictors of Response to Physical Therapy
大体时间:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Performance of machine learning models using pre-treatment digital biomarkers, demographics, and clinical factors to predict non-response to physical therapy (no meaningful symptom improvement), reported as area under the ROC curve (AUC). |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.